Trials
Search / Trial NCT05658289

Latarjet vs Anatomic Glenoid Reconstruction

Launched by NOVA SCOTIA HEALTH AUTHORITY · Dec 12, 2022

Trial Information

Current as of January 21, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is studying two different surgical methods for treating shoulder dislocations caused by bone loss: the Latarjet procedure and Anatomic Glenoid Reconstruction (AGR). Both surgeries aim to help people who have experienced shoulder dislocations regain function, reduce pain, and lower the chances of the dislocation happening again. The Latarjet method is known for its effectiveness but has some risks of complications, while the AGR is a newer option that also shows promise with fewer complications. The goal of this trial is to compare the results of these two surgeries to see which one works better for patients.

To participate in this trial, individuals should have experienced at least one shoulder dislocation and have a CT scan showing significant bone loss (more than 20%). Unfortunately, those with other specific shoulder problems or who have a history of substance abuse cannot join. Participants will receive one of the two surgical treatments and will be monitored before and after the surgery to evaluate their recovery and overall outcomes. This study is currently looking for volunteers and aims to provide clearer insights into the best surgical options for shoulder dislocation patients.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patients with one or more instances of anterior shoulder dislocation; pre-operative CT scan illustrating \>20% bone loss.
  • Exclusion Criteria:
  • posterior shoulder instability; multidirectional shoulder instability; massive rotator cuff teats (MRI proven); history of substance abuse, patients unable to provide informed consent, patients refusing randomization.

Trial Officials

Ivan Wong, MD

Principal Investigator

Nova Scotia Health Authority, Orthopaedic Surgeon

About Nova Scotia Health Authority

The Nova Scotia Health Authority (NSHA) is a leading healthcare organization dedicated to enhancing the health and well-being of individuals and communities across Nova Scotia, Canada. As the largest provider of health services in the province, NSHA is committed to advancing clinical research and innovation through rigorous clinical trials that aim to improve patient care and outcomes. With a focus on collaboration, NSHA engages healthcare professionals, researchers, and patients to address pressing health challenges and contribute to the global body of medical knowledge. By fostering a culture of evidence-based practice and continual improvement, NSHA plays a pivotal role in shaping the future of healthcare delivery in the region.

Locations

Halifax, Nova Scotia, Canada

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0

Similar Trials